Loading...
SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
Background As immune checkpoint inhibitor (ICI) therapies (PD(L)1 and CTLA-4 inhibitors) are increasingly used for treating malignancy, immune-related adverse events (irAEs) are being encountered by clinicians more frequently. Obesity is a pro-inflammatory metabolic state that has been associated wi...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552273/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-094 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|